These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514 [TBL] [Abstract][Full Text] [Related]
6. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case. Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840 [TBL] [Abstract][Full Text] [Related]
7. Chemoembolization for hepatocellular carcinoma via the inferior pancreaticoduodenal artery in patients with celiac artery stenosis. Okazaki M; Higashihara H; Ono H; Koganemaru F; Fujimitsu R; Mizuma Y; Nakamura T; Sato S; Kimura S; Kodama S Acta Radiol; 1993 Jan; 34(1):20-5. PubMed ID: 8381295 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes. Wang Y; Zhang J; Gao Y; Yu M; Gong Y; Yu G Chin Med J (Engl); 1999 Mar; 112(3):264-8. PubMed ID: 11593564 [TBL] [Abstract][Full Text] [Related]
9. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations]. Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994 [TBL] [Abstract][Full Text] [Related]
10. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis. Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Tanaka M; Sakai T; Inoue R; Eguchi S; Majima Y; Abe M Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma]. Shi Z; Guo Y; Liu D Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839 [TBL] [Abstract][Full Text] [Related]
13. [A case of hepatoma suspected pulmonary emboli following transcatheter arterial embolization]. Ozaki M; Miyagawa K; Takano H; Sekiya T; Natsuyama N; Nakano M Rinsho Hoshasen; 1989 Jan; 34(1):165-7. PubMed ID: 2542675 [TBL] [Abstract][Full Text] [Related]
15. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma. Lin WY; Wang SJ; Yeh SH Neoplasma; 1995; 42(2):89-92. PubMed ID: 7617083 [TBL] [Abstract][Full Text] [Related]
16. [Temporary placement of inferior vena cava filter prior to transcatheter arterial embolization (TAE) for hepatocellular carcinoma with IVC tumor thrombus--prevention of pulmonary tumor emboli after TAE]. Izaki K; Matsumoto S; Konishi J; Higashino T; Tsurusaki M; Fukuda T; Akasaka Y; Mori T; Sugimoto K; Fujii M; Sugimura K; Yoshikawa T; Hirota S; Hayashi Y Gan To Kagaku Ryoho; 2001 Oct; 28(11):1708-11. PubMed ID: 11708015 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous regression of multiple lung metastases following regression of hepatocellular carcinoma after transcatheter arterial embolization. A case report. Heianna J; Miyauchi T; Suzuki T; Ishida H; Hashimoto M; Watarai J Hepatogastroenterology; 2007; 54(77):1560-2. PubMed ID: 17708299 [TBL] [Abstract][Full Text] [Related]
19. [The change of hepatic energy status after transcatheter arterial embolization (TAE) for hepatocellular carcinoma--a study using 31P-MRS]. Taniguchi K; Kaminaga T; Sakon M; Umeshita K; Yamada T; Takeda Y; Higaki N; Aoki T; Ohzato H; Hasuike Y; Gotoh M; Murakami T; Nakamura H; Monden M Gan To Kagaku Ryoho; 1997 Sep; 24(12):1632-4. PubMed ID: 9382494 [TBL] [Abstract][Full Text] [Related]
20. [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma]. Shimamura Y; Ishii M; Shima Y; Takenaka H; Taniguchi H; Watanabe H; Kitai S; Sugai S; Takahashi A; Kitaya T Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]